Cinacalcet for Symptomatic Hypercalcemia Caused by AP2S1 Mutations

Ítems similars

• Cinacalcet corrects hypercalcemia in mice with an inactivating Gα(11) mutation
  per: Howles, Sarah A., et al.
  Publicat: (2017)
• Mutations Affecting G-Protein Subunit α(11) in Hypercalcemia and Hypocalcemia
  per: Nesbit, M. Andrew, et al.
  Publicat: (2013)
• A G‐protein Subunit‐α11 Loss‐of‐Function Mutation, Thr54Met, Causes Familial Hypocalciuric Hypercalcemia Type 2 (FHH2)
  per: Gorvin, Caroline M, et al.
  Publicat: (2016)
• Cinacalcet Rectifies Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss‐of‐Function Gα(11) Mutation
  per: Gorvin, Caroline M, et al.
  Publicat: (2017)
• Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3
  per: Nesbit, M. Andrew, et al.
  Publicat: (2012)